[Expression of nuclear factor-kappaB in bone marrow cells from patients with acute leukemia and its relationship with

Hai-Yan Hu1, Hui Sun, Dian-Bin Zou

  • 1Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Insights

Nuclear factor-kappa B (NF-kappaB) and matrix metalloproteinases (MMPs) are overexpressed in acute leukemia (AL). This suggests NF-kappaB activation by Ras may drive AL progression by upregulating MMPs, facilitating leukemic cell invasion.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Context:

  • Acute leukemia (AL) is a heterogeneous hematologic malignancy.
  • The role of specific molecular pathways, such as NF-kappaB and MMPs, in AL pathogenesis requires further elucidation.
  • Understanding these pathways could reveal novel therapeutic targets.

Purpose:

  • To investigate the expression levels of NF-kappaB, P21, MMP-2, and MMP-9 in acute leukemia bone marrow cells.
  • To determine the correlation between NF-kappaB expression and the expression of P21, MMP-2, and MMP-9 in AL.
  • To explore the potential mechanism by which NF-kappaB influences MMP expression and leukemic cell behavior.

Summary:

  • Immunocytochemical analysis revealed significantly higher expression of NF-kappaB, P21, MMP-2, and MMP-9 in untreated acute leukemia cells compared to remission and normal controls.
  • A strong positive correlation was observed between NF-kappaB expression and the expression of P21, MMP-2, and MMP-9.
  • Results indicate that Ras-activated NF-kappaB upregulates MMP-2 and MMP-9 gene expression, potentially enhancing leukemic cell invasiveness.

Impact:

  • This study identifies NF-kappaB and MMPs as potential biomarkers for acute leukemia.
  • The findings suggest that the Ras-NF-kappaB-MMP axis plays a critical role in leukemic cell migration and bone marrow barrier penetration.
  • Targeting this pathway could offer a novel therapeutic strategy for managing acute leukemia.